These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 3876382

  • 1. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD, Allavena P, Ortaldo JR.
    J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
    [Abstract] [Full Text] [Related]

  • 2. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
    Pistoia V, Cozzolino F, Torcia M, Castigli E, Ferrarini M.
    J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM, Bonnard GD.
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL, Ambrus JL, Fauci AS.
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K, Hirano T, Ishibashi K, Nakano N, Taga T, Sugamura K, Yamamura Y, Kishimoto T.
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [Abstract] [Full Text] [Related]

  • 12. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S, Giudizi GM, Maggi E, Almerigogna F, Biagiotti R, Del Prete G, Mazzetti M, Alessi A, Vercelli D, Ricci M.
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [Abstract] [Full Text] [Related]

  • 13. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 14. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S, Taguchi M, Watanabe Y, Okubo T, Murachi T, Uchino H, Hanaoka M.
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [Abstract] [Full Text] [Related]

  • 15. Production of multiple cytokines by clones of human large granular lymphocytes.
    Allavena P, Scala G, Djeu JY, Procopio AD, Oppenheim JJ, Herberman RB, Ortaldo JR.
    Cancer Immunol Immunother; 1985 Dec; 19(2):121-6. PubMed ID: 3921231
    [Abstract] [Full Text] [Related]

  • 16. Signal requirements for growth and differentiation of activated murine B lymphocytes.
    Müller W, Kühn R, Goldmann W, Tesch H, Smith FI, Radbruch A, Rajewsky K.
    J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
    [Abstract] [Full Text] [Related]

  • 17. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T.
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [Abstract] [Full Text] [Related]

  • 18. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A, Kehrl JH, Butler JL, Fauci AS.
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [Abstract] [Full Text] [Related]

  • 19. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M, Matsushima K, Oppenheim JJ.
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [Abstract] [Full Text] [Related]

  • 20. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E, Targan SR.
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.